MindBio Therapeutics Corp (MBIO)

Currency in CAD
1.00
0.00(0.00%)
Delayed Data·
MBIO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.961.00
52 wk Range
0.506.00
Key Statistics
Bid/Ask
0.03 / 0.03
Prev. Close
0.03
Open
0.98
Day's Range
0.96-1
52 wk Range
0.5-6
Volume
-
Average Volume (3m)
10.14K
1-Year Change
-75.5%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MBIO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

MindBio Therapeutics Corp News & Analysis

Show more
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Feb 26, 2026
EPS / Forecast
-1.64 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

MBIO Income Statement

Compare MBIO to Peers and Sector

Metrics to compare
MBIO
Peers
Sector
Relationship
P/E Ratio
−1.2x−1.7x−0.5x
PEG Ratio
−0.01−0.030.00
Price/Book
−3.8x1.2x2.6x
Price / LTM Sales
-5.5x3.2x
Upside (Analyst Target)
-242.8%50.8%
Fair Value Upside
Unlock16.8%7.7%Unlock

MindBio Therapeutics Corp., together with its subsidiaries, engages in researching, developing, and testing psychedelic substances as a potential treatment for the management of various mental health conditions in Australasia. Its lead drug candidate is MB22001, a form of lysergic acid diethylamide in Phase 2A trials. The company also develops wearable devices to collect biometric data in mental health patients taking psychedelic medicines; and invests in research that forms the basis for developing novel and clinically proven treatments for debilitating health conditions, such as depression, anxiety, PTSD, and chronic pain. MindBio Therapeutics Corp. was incorporated in 2021 and is headquartered in Vancouver, Canada.

FAQ

What Is the MindBio Therapeutics (MBIO) Stock Price Today?

The MindBio Therapeutics stock price today is 1.00 CAD.

What Stock Exchange Does MindBio Therapeutics Trade On?

MindBio Therapeutics is listed and trades on the Canadian Securities Exchange.

What Is the Stock Symbol for MindBio Therapeutics?

The stock symbol for MindBio Therapeutics is "MBIO."

What Is the MindBio Therapeutics Market Cap?

As of today, MindBio Therapeutics market cap is 7.28M CAD.

What Is MindBio Therapeutics's Earnings Per Share (TTM)?

The MindBio Therapeutics EPS (TTM) is -0.01.

From a Technical Analysis Perspective, Is MBIO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has MindBio Therapeutics Stock Split?

MindBio Therapeutics has split 1 times.

What is the current trading status of MindBio Therapeutics (MBIO)?

As of Apr 30, 2026, MindBio Therapeutics (MBIO) is trading at a price of 1.00 CAD, with a previous close of 0.03 CAD. The stock has fluctuated within a day range of 0.96 CAD to 1.00 CAD, while its 52-week range spans from 0.50 CAD to 6.00 CAD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.